The latest thinking in PSA testing is that prostate cancer screening should not be offered routinely to all men. Because of the testing, many men are diagnosed and treated for cancers that would not have made them sick or shortened their lives. For such men, the treatment—which can produce side effects—is worse than the disease. Although PSA screening has been thought to offer most potential benefit to men at elevated risk, such as African American men and men with a family history of prostate cancer, this has not been shown in studies conducted to date.
To continue reading this article, you must login
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.